164 related articles for article (PubMed ID: 27028131)
1. Glycaemic control modifies the haptoglobin 2 allele-conferred susceptibility to coronary artery disease in Type 1 diabetes.
Costacou T; Evans RW; Orchard TJ
Diabet Med; 2016 Nov; 33(11):1524-1527. PubMed ID: 27028131
[TBL] [Abstract][Full Text] [Related]
2. Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes.
Costacou T; Ferrell RE; Orchard TJ
Diabetes; 2008 Jun; 57(6):1702-6. PubMed ID: 18332093
[TBL] [Abstract][Full Text] [Related]
3. Glycaemic variability is associated with coronary artery calcium in men with Type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes study.
Snell-Bergeon JK; Roman R; Rodbard D; Garg S; Maahs DM; Schauer IE; Bergman BC; Kinney GL; Rewers M
Diabet Med; 2010 Dec; 27(12):1436-42. PubMed ID: 21059097
[TBL] [Abstract][Full Text] [Related]
4. Glycaemic control and excess risk of major coronary events in persons with type 1 diabetes.
Matuleviciene-Anängen V; Rosengren A; Svensson AM; Pivodic A; Gudbjörnsdottir S; Wedel H; Kosiborod M; Haraldsson B; Lind M
Heart; 2017 Nov; 103(21):1687-1695. PubMed ID: 28710186
[TBL] [Abstract][Full Text] [Related]
5. Haptoglobin genotype predicts development of coronary artery calcification in a prospective cohort of patients with type 1 diabetes.
Simpson M; Snell-Bergeon JK; Kinney GL; Lache O; Miller-Lotan R; Anbinder Y; Rewers MJ; Levy AP
Cardiovasc Diabetol; 2011 Nov; 10():99. PubMed ID: 22098782
[TBL] [Abstract][Full Text] [Related]
6. Genetics of diabetic cardiovascular disease: identification of a major susceptibility gene.
Levy AP
Acta Diabetol; 2003 Dec; 40 Suppl 2():S330-3. PubMed ID: 14704863
[TBL] [Abstract][Full Text] [Related]
7. The Haptoglobin genotype predicts cardio-renal mortality in type 1 diabetes.
Costacou T; Orchard TJ
J Diabetes Complications; 2016 Mar; 30(2):221-6. PubMed ID: 26684170
[TBL] [Abstract][Full Text] [Related]
8. Poor glycaemic control is associated with increased risk of neurodevelopmental disorders in childhood-onset type 1 diabetes: a population-based cohort study.
Liu S; Kuja-Halkola R; Larsson H; Lichtenstein P; Ludvigsson JF; Svensson AM; Gudbjörnsdottir S; Tideman M; Serlachius E; Butwicka A
Diabetologia; 2021 Apr; 64(4):767-777. PubMed ID: 33454829
[TBL] [Abstract][Full Text] [Related]
9. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB
Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048
[TBL] [Abstract][Full Text] [Related]
10. Haptoglobin genotype and cerebrovascular disease incidence in type 1 diabetes.
Costacou T; Secrest AM; Ferrell RE; Orchard TJ
Diab Vasc Dis Res; 2014 Sep; 11(5):335-42. PubMed ID: 24994788
[TBL] [Abstract][Full Text] [Related]
11. Interaction between angiotensin-converting enzyme genotype and glycaemic control influences lipoprotein levels in type 2 diabetes mellitus.
Tkác I; Salagovic J; Kozárová M; Rosolová H; Molcányiová A; Mosorjáková D; Chleborádová M; Kalina I
Wien Klin Wochenschr; 2003 Jan; 115(1-2):36-40. PubMed ID: 12658909
[TBL] [Abstract][Full Text] [Related]
12. Is glycaemia or insulin dose the stronger risk factor for coronary artery disease in type 1 diabetes?
Conway B; Costacou T; Orchard T
Diab Vasc Dis Res; 2009 Oct; 6(4):223-30. PubMed ID: 20368215
[TBL] [Abstract][Full Text] [Related]
13. Lack of correlation between the optimal glycaemic control and coronary micro vascular dysfunction in patients with diabetes mellitus: a cross sectional study.
Valenzuela-Garcia LF; Matsuzawa Y; Sara JD; Kwon TG; Lennon RJ; Lerman LO; Ruiz-Salmeron RJ; Lerman A
Cardiovasc Diabetol; 2015 Aug; 14():106. PubMed ID: 26268857
[TBL] [Abstract][Full Text] [Related]
14. Glycaemic control and excess risk of ischaemic and haemorrhagic stroke in patients with type 1 diabetes: a cohort study of 33 453 patients.
Ståhl CH; Lind M; Svensson AM; Gudbjörnsdottir S; Mårtensson A; Rosengren A
J Intern Med; 2017 Mar; 281(3):261-272. PubMed ID: 27925333
[TBL] [Abstract][Full Text] [Related]
15. Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC).
Prince CT; Becker DJ; Costacou T; Miller RG; Orchard TJ
Diabetologia; 2007 Nov; 50(11):2280-8. PubMed ID: 17768606
[TBL] [Abstract][Full Text] [Related]
16. Glycaemic status influences the nature and severity of coronary artery disease.
Berry C; Noble S; Grégoire JC; Ibrahim R; Levesquie S; Lavoie MA; L'Allier PL; Tardif JC
Diabetologia; 2010 Apr; 53(4):652-8. PubMed ID: 20225394
[TBL] [Abstract][Full Text] [Related]
17. The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus.
Dalan R; Liuh Ling G
Eur J Prev Cardiol; 2018 Sep; 25(14):1502-1519. PubMed ID: 29799294
[TBL] [Abstract][Full Text] [Related]
18. The association between sociodemographic and clinical characteristics and poor glycaemic control: a longitudinal cohort study.
McBrien KA; Manns BJ; Hemmelgarn BR; Weaver R; Edwards AL; Ivers N; Rabi D; Lewanczuk R; Braun T; Naugler C; Campbell D; Saad N; Tonelli M
Diabet Med; 2016 Nov; 33(11):1499-1507. PubMed ID: 26526088
[TBL] [Abstract][Full Text] [Related]
19. Association of the genetic variant rs2000999 with haptoglobin and diabetic macrovascular diseases in Chinese patients with type 2 diabetes.
Wang S; Zhang R; Wang T; Jiang F; Hu C; Jia W
J Diabetes Complications; 2019 Feb; 33(2):178-181. PubMed ID: 30366827
[TBL] [Abstract][Full Text] [Related]
20. Glycemic Control Status After Percutaneous Coronary Intervention and Long-Term Clinical Outcomes in Patients With Type 2 Diabetes Mellitus.
Hwang JK; Lee SH; Song YB; Ahn J; Carriere K; Jang MJ; Park TK; Choi SH; Yang JH; Choi JH; Lee SH; Gwon HC; Hahn JY
Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28373177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
